Can a cold virus fight melanoma? new study aims to stop Cancer's first step

NCT ID NCT06216938

Recruiting now Disease control Sponsor: Yana Najjar Source: ClinicalTrials.gov ↗

First seen Apr 15, 2026 · Last updated May 15, 2026 · Updated 4 times

Summary

This study tests a genetically modified herpes virus (RP1) injected directly into melanoma tumors. The goal is to see if it can kill cancer cells and train the immune system to attack the cancer, reducing the chance it spreads to nearby lymph nodes. About 25 adults with thick or high-risk melanoma will participate. The main measure is how many have cancer in their sentinel lymph node after treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

UPMC Hillman Cancer Center
RECRUITING

Pittsburgh, Pennsylvania, 15232, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

MELANOMA